Literature DB >> 12641994

Gastrointestinal Infections Caused by Cytomegalovirus.

David A. Bobak1.   

Abstract

Cytomegalovirus (CMV) is an important human pathogen, causing a variety of syndromes ranging from asymptomatic infections to life-threatening end-organ disease. Infections of the gastrointestinal tract are an especially common form of disease caused by CMV and are usually manifest as luminal infections, such as esophagitis or colitis. Solid organ disease caused by CMV is also known to occur, with hepatitis being the most common syndrome. The large majority of cases of tissue-invasive disease caused by CMV have been reported to occur in immunocompromised hosts. Patients at highest risk for serious CMV-mediated disease are commonly HIV infected, recipients of transplants, or are receiving potent immunosuppressive medications. Intriguingly, several recent reports have discussed the previously underappreciated role of serious forms of CMV-mediated disease occurring in immunocompetent patients. This paper reviews several recent reports addressing important aspects related to the diagnosis, treatment, and management of CMV infections of the gastrointestinal tract.

Entities:  

Year:  2003        PMID: 12641994     DOI: 10.1007/s11908-003-0044-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  50 in total

1.  Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.

Authors:  E Morales; A Andrés; E González; J C Herrero; M A Muñoz; M Ortiz; B Espejo; C Lumbreras; J M Morales; J M Aguado
Journal:  Transplant Proc       Date:  2002-02       Impact factor: 1.066

Review 2.  Progress in understanding cytomegalovirus drug resistance.

Authors:  V C Emery
Journal:  J Clin Virol       Date:  2001-06       Impact factor: 3.168

Review 3.  Clinical aspects and management of cytomegalovirus infection.

Authors:  J G P Sissons; A J Carmichael
Journal:  J Infect       Date:  2002-02       Impact factor: 6.072

Review 4.  Cytomegalovirus (CMV) resistance to antivirals.

Authors:  W L Drew; C V Paya; V Emery
Journal:  Am J Transplant       Date:  2001-11       Impact factor: 8.086

5.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

6.  Cytomegalovirus hepatitis confirmed by in situ hybridization in 3 immunocompetent infants.

Authors:  H Tajiri; K Kozaiwa; K Tanaka-Taya; K Tada; T Takeshima; K Yamanishi; S Okada
Journal:  Scand J Infect Dis       Date:  2001

7.  Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency.

Authors:  F H Ng; T N Chau; T C Cheung; C Kng; S Y Wong; W F Ng; K C Lee; E Chan; S T Lai; W C Yuen; C M Chang
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

8.  The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.

Authors:  R Teixeira; S Pastacaldi; S Davies; A P Dhillon; V C Emery; K Rolles; B Davidson; D Patch; A K Burroughs
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

9.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

10.  Cytomegalovirus pp65 antigen-guided preemptive therapy with ganciclovir in solid organ transplant recipients: a prospective, double-blind, placebo-controlled study.

Authors:  A C Koetz; R Delbrück; A Furtwängler; F T Hufert; D Neumann-Haefelin; G Kirste; U Meyer-König
Journal:  Transplantation       Date:  2001-10-15       Impact factor: 4.939

View more
  6 in total

1.  Gastrointestinal complications in renal transplant patients: a large, single-center experience.

Authors:  Nandini Nagaraj; Barry Kahan; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

2.  Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.

Authors:  Tracy L Lemonovich; Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

3.  Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Authors:  C A Q Santos; D C Brennan; V J Fraser; M A Olsen
Journal:  Transplant Proc       Date:  2014-12       Impact factor: 1.066

4.  Difficulties in assessing cytomegalovirus-associated gastric perforation in an HIV-infected patient.

Authors:  Bruno Mégarbane; Dabor Résière; Jacqueline Ferrand; Laurent Raskine; Kouroche Vahedi; Frédéric J Baud
Journal:  BMC Infect Dis       Date:  2005-04-13       Impact factor: 3.090

5.  Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients.

Authors:  Panu Wetwittayakhlang; Natthapat Rujeerapaiboon; Poowadon Wetwittayakhlung; Pimsiri Sripongpun; Nannapat Pruphetkaew; Sawangpong Jandee; Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Gastroenterol Res Pract       Date:  2021-04-06       Impact factor: 2.260

6.  Unusual Epstein-Barr esophageal infection in an immunocompetent patient: a case report.

Authors:  Magdalini Pape; Kalliopi Mandraveli; Ioannis Sidiropoulos; Dimitrios Koliouskas; Stella Alexiou-Daniel; Filanthi Frantzidou
Journal:  J Med Case Rep       Date:  2009-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.